Pasireotide Treatment for Neuroendocrine Tumor

NCT02779257 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Subject passed away prior to enrollment

Conditions

Interventions

Sponsor

University of Maryland, Baltimore

Collaborators